share_log

Cibus, Albaugh LLC and RTDC Company Limited Affirm Collaboration to Enable Commercialization of Cibus' First Gene Edited Weed Management Solution for U.S. Rice Growers

Cibus, Albaugh LLC and RTDC Company Limited Affirm Collaboration to Enable Commercialization of Cibus' First Gene Edited Weed Management Solution for U.S. Rice Growers

Cibus、Albaugh LLC和RTDC有限公司確認合作,以促進Cibus第一個基因編輯雜草管理解決方案在美國稻農中的商業化。
GlobeNewswire ·  12/16 20:00

Cibus' Rice Herbicide Tolerance (HT-3) Commercialization Efforts Continue Promising Progress to deliver a new Weed Management Solution for Farmers in the U.S.

Cibus的稻米除草劑耐受性(Ht-3)商業化努力繼續取得令人鼓舞的進展,以爲美國農民提供新的除草管理解決方案。

Cibus and its partners Albaugh and RTDC Continue Their Research and Development Collaboration to Enable Commercialization of Cibus' Clethodim-Tolerant HT-3 Rice Trait

Cibus及其合作伙伴Albaugh和RTDC繼續他們的研發合作,以促進Cibus的克樂多耐受Ht-3稻米特性的商業化。

SAN DIEGO, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties announced an agreement affirming its collaboration with RTDC Corporation Limited and Albaugh LLC to provide Clethodim as part of Cibus' weed management solution for U.S. rice farmers using Cibus' HT-3 trait. This continued collaboration with Albaugh, a global leader in crop protection, lends complementary market development and herbicide registration expertise and experience to Cibus' gene editing trait expertise. The collaboration is instrumental to Cibus' herbicide resistant rice trait commercialization efforts as Cibus also continues its work with its U.S. rice seed customers to bring its Clethodim-tolerant trait to market. These seed and crop protection collaborations are expected to bring together the rice production knowledge and expertise needed to successfully deliver improved rice weed management solutions for U.S. rice growers.

聖地亞哥,2024年12月16日(全球新聞稿)——Cibus,Inc.(納斯達克:CBUS),一家領先的農產品技術公司,開發和許可植物特性給種子公司以獲得特許權使用費,宣佈與RTDC有限公司和Albaugh LLC達成協議,確認其合作,以向使用Cibus的Ht-3萬億.ait的美國稻農提供克樂多作爲Cibus除草管理解決方案的一部分。這一與全球作物保護領導者Albaugh的持續合作,帶來了補充的市場開發和除草劑註冊專業知識和經驗,增強了Cibus的基因編輯特性專長。這一合作對於Cibus的除草劑抗性稻米特性的商業化努力至關重要,同時Cibus還繼續與其美國稻種客戶合作,將其克樂多耐受特性推向市場。這些種子與作物保護的合作預計將匯聚所需的稻米生產知識和專業知識,以成功提供改善的美國稻農除草管理解決方案。

Weed pressure impacts crop yield and quality. Herbicide tolerance traits are an important tool for growers to manage weeds and are a key product area of the multi-billion-dollar trait industry globally. Cibus' Clethodim tolerant HT-3 trait is an important breakthrough for a novel weed management solution for rice farmers and is one of the two herbicide tolerant traits in rice developed by Cibus that are expected to give rice growers excellent new solutions to manage weeds. It expected to be the first of several stacked weed management traits in rice from Cibus. Cibus currently has four seed partners for this trait: two in the United States and two in South America and is in discussion with other major rice seed companies to advance HT-3 rice in Asia.

雜草壓力影響作物產量和質量。除草劑耐受性狀是種植者管理雜草的重要工具,也是全球數十億美元性狀行業的一個關鍵產品領域。Cibus的Clethodim耐受性Ht-3性狀是水稻農民新型雜草管理解決方案的重要突破,是Cibus開發的兩種除草劑耐受性狀之一,預計將爲水稻種植者提供出色的新解決方案來管理雜草。它預計將是Cibus在水稻領域推出的幾種疊加雜草管理性狀中的第一個。Cibus目前在這一性狀方面有四個種子合作伙伴:兩個在美國,兩個在南美,並正在與其他主要水稻種子公司討論,以推動Ht-3水稻在亞洲的發展。

Chad W. Shelton, Albaugh's Group Director for Herbicide Tolerant Crops, stated, "This strategic collaboration and innovative technology has a strong potential to help rice growers in the U.S. and strategic rice markets around the globe keep pace with the most up-to-date herbicide-tolerant crop technologies for assuring high yields and crop quality. Albaugh is excited to be a part of this strategic partnership to develop for rice growers a cropping system powered by the HT-3 trait to help create and deliver performance value."

查德·W·謝爾頓,Albaugh的除草劑耐受作物集團董事,表示:「這一戰略合作與創新科技在全球範圍內有着強大的潛力,可以幫助美國和其他戰略稻米市場的稻農跟上最新的除草劑耐受作物技術,以確保高產和作物質量。Albaugh很高興能成爲這一戰略伙伴關係的一部分,爲稻農開發一個由Ht-3特性驅動的種植系統,幫助創造和提供性能價值。」

Calvin Lu, Vice General Manager of RTDC, commented, "This technology combines the best of Gene Editing technologies from Cibus and superior herbicides provided by Albaugh to help rice growers to increase weed management options with better efficacy against difficult weeds. We are proud to be part of this project combining strengths of three companies in terms of technologies and geographies."

瑞田公司的副總經理Calvin Lu評論道:「這項技術結合了Cibus的最佳基因編輯技術和Albaugh提供的優質除草劑,幫助稻農增加更有效的除草管理選項以應對困難的雜草。我們很自豪能夠參與這個項目,結合三家公司在技術和地域上的優勢。」

Norm Sissons, Senior Vice President of Seeds and Traits at Cibus, added, "This partnership with Albaugh completes a critical component of our commercial strategy to bring our Clethodim-tolerant HT-3 trait to market. As we further our collaboration with Albaugh and its professional team of experts with a strong commercial focus enabling getting products to market, we see a promising path to bring Cibus' novel weed management solution to Rice growers."

Cibus的種子和特性高級副總裁Norm Sissons補充道:「與Albaugh的合作完善了我們商業策略中的一個關鍵組成部分,以將我們的Clethodim耐受Ht-3萬億.ait推向市場。隨着我們與Albaugh及其專業專家團隊在促進商業方面的進一步合作,我們看到了一條有前景的道路,可以將Cibus的新型除草管理解決方案帶給稻農。」

About Cibus

關於Cibus

Cibus is a leader in gene edited productivity traits that address critical productivity and sustainability challenges for farmers such as diseases and pests which the United Nations estimates cost the global economy approximately $300 billion annually. Cibus is not a seed company. It is a technology company that uses gene editing to develop and license traits to seed companies in exchange for royalties on seed sales. Cibus' long-term focus is productivity traits for farmers for the major global row crops with large acreage such as canola, rice, and soybean. Cibus is a technology leader in high-throughput gene editing technology that is expected to enable it to develop and commercialize plant traits at a fraction of the time and cost of conventional breeding. Cibus has developed a current pipeline of five productivity traits including important traits for weed management in Rice, Pod Shatter Reduction, and Sclerotinia (disease) resistance, which are its near-term focus.

Cibus是基因編輯生產力特徵的領導者,解決農民面臨的關鍵生產力和可持續性挑戰,例如疾病和害蟲,聯合國估計這些挑戰每年給全球經濟造成約3000億的損失。Cibus並不是一家種子公司。它是一家科技公司,通過基因編輯向種子公司開發和授權特徵,換取種子銷售的特許權使用費。Cibus的長期集中在主要的全球大宗農作物上,爲農民提供生產力特徵,這些作物的種植面積很大,如油菜、稻米和大豆。Cibus在高通量基因編輯技術方面處於行業領先地位,預計這將使其以遠低於傳統育種的時間和成本開發和商業化植物特徵。Cibus目前已開發出五個生產力特徵的管線,包括稻米的雜草管理重要特徵、豆莢破碎減少和白粉病(病害)抵抗,這是其近期的重點。

Forward-Looking Statements

前瞻性聲明

This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. In some cases, you can identify these statements by forward-looking words such as "anticipates," "believes," "continue," "estimates," "expects," "intends," "may," "might," "plans," "predicts," "projects," "should," "targets," "will," or the negative of these terms and other similar terminology. Forward-looking statements in this press release include, but are not limited to, statements regarding the anticipated closing of the offering and the expected use of the proceeds from the offering. Completion of the offering is subject to numerous factors, many of which are beyond Cibus' control, including, without limitation, market conditions, failure to satisfy customary closing conditions and the risk factors and other matters set forth in the prospectus supplement and accompanying prospectus included in the registration statement and the documents incorporated by reference therein. You are cautioned not to place undue reliance on any forward-looking statements made by Cibus' management, which are based only on information currently available to it when, and speak only as of the date, such statement is made. Cibus does not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by law.

本新聞稿包含1995年《美國私人證券訴訟改革法》安全港條款意義中的「前瞻性陳述」。在某些情況下,您可以通過前瞻性詞語識別這些陳述,例如「預計」、「相信」、「繼續」、「估計」、「期望」、「打算」、「可能」、「計劃」、「預測」、「項目」、「應」、「目標」、「將」,或這些術語的否定形式及其他類似的術語。本新聞稿中的前瞻性陳述包括但不限於關於預期完成發行和預計使用發行所得的陳述。發行的完成受許多因素的影響,其中許多超出Cibus的控制範圍,包括但不限於市場條件、未能滿足慣常的完成條件及登記聲明和相關招股說明書中列出風險因素和其他事項。您被告誡不要對Cibus管理層所作的任何前瞻性陳述過於依賴,這些陳述僅基於當前可獲得的信息,並僅在該聲明作出時的日期生效。Cibus不承擔任何義務公開提供對任何前瞻性陳述的修訂或更新,無論是由於新信息、未來發展還是其他原因,除非法律另有要求。

CIBUS CONTACTS:

CIBUS 聯繫人:

INVESTOR RELATIONS
Karen Troeber
ktroeber@cibus.com
858-450-2636

投資者關係
卡倫·特羅伯
ktroeber@cibus.com
858-450-2636

Jeff Sonnek – ICR
jeff.sonnek@icrinc.com

傑夫·索內克 – ICR
jeff.sonnek@icrinc.com

MEDIA RELATIONS
Colin Sanford
colin@bioscribe.com
203-918-4347

媒體關係
科林·桑福德
colin@bioscribe.com
203-918-4347


声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論